Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Robert Gereau
Washington University, Department: Anesthesiology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Neurolux Systems
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Based on WU’s Research COI Policy and the Procedures for Determining and Managing Research Financial Conflicts of Interests, the CIRC determined Dr. Gereau’s personal financial relationship with Neurolux Systems, related to the above referenced research, creates a financial conflict of interest due to the following reasons:
•The primary focus of Neurolux Systems, an entity with which Dr. Gereau owns equity, is to commercialize the IP being developed and evaluated in the above mentioned research.
• Dr. Gereau’s role as the Principal Investigator in designing the study, collecting/analyzing/reviewing the data, reporting the results, oversight of the research, and supervising individuals involved with the research could directly affect the outcome of the study.
While the CIRC determined a financial conflict of interest exists, it concluded there are mitigating factors that help address the situation:
•The research is basic in nature and in its early stages; as such, the outcomes of the research is unlikely to directly impact Dr. Gereau’s financial interest.
•Dr. Gereau is uniquely qualified by virtue of his expertise and experience, and the research could not be conducted as effectively without his involvement.
•There is currently no active license for the IP being evaluated.
•Additionally, a plan has been developed to mitigate Dr. Gereau’s financial conflict of interest.
Multimodal biocompatible microLED devices for diverse neuroscience applications
A better and more complete understanding of the specific wiring of the brain and peripheral nerves is critical for developing effective treatments for nervous system diseases and disorders including chronic pain, depression, and addiction. The experiments and engineering described in this proposal aim to develop, test, and interface micro-devices that can safely and stably interact with the nervous system in new ways to both understand brain circuitry and to manipulate that circuitry to reduce the effects of nervous system disease and dysfunction.
Filed on February 19, 2016.
Tell us what you know about Robert Gereau's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.